Jyong Biotech Showcases Botanical Drug Portfolio at BIO 2026 International Convention

ConferenceNeutral

AI Analysis

Summary

Jyong Biotech (MENS) participated in the BIO International Convention 2026 in San Diego to showcase its botanical drug portfolio and conduct discussions with pharmaceutical companies and investment institutions. The company has maintained continuous participation in the convention for over a decade.

Importance:2/10

Sentiment:

0.20

conferencebotanical drugsplant-derived therapeuticsBIO 2026partnership discussions

Related Companies

$MENS

Read the original article

Published by GlobeNewswire Pharma on July 2, 2026 12:00 PM

Read Original